This program is focused on central activities required for the development of small organic molecules as cancer chemotherapeutic agents. Members of this program use a wide variety of approaches, including chemical, biochemical, cellular, and animal methods to design and discover drugs. These approaches include (but are not limited to):
Natural Product-Based Drug Design and Discovery – Synthesis of anticancer natural products and analogs thereof and biological studies on their mechanism of action.
Biologically-Targeted Drug Design – Design, synthesis, and biological evaluation of synthetic compounds as potential inhibitors of anticancer enzyme targets, and antagonists of anticancer receptors.
Screening of Biological Targets for Drug Discovery – Development and utilization of methods, including systems biology methods, for the high-throughput evaluation of potential anticancer agents.
- Preclinical Models for Drug Development – Evaluation of potential chemotherapeutic and chemopreventive agents in cellular and animal cancer models.
Specific examples of activities in this program include:
Development of new synthetic routes to natural products known to function as antitumor or chemopreventive agents.
Mechanistic evaluation of new anticancer natural products.
Design and synthesis of targeted protein kinase inhibitors.
Design and synthesis of inhibitors of post-translational modifications.
Design and synthesis of topoisomerase inhibitors.
Development of systems methods for discovery of novel potential anticancer targets.
- Studies of potential chemotherapeutic agents in mouse xenograph and other animal models.
R. Timothy Bentley, Veterinary Clinical Sciences
Richard F. Borch, Medicinal Chemistry & Molecular Pharmacology
Michael Childress, Veterinary Clinical Sciences
David Colby, Medicinal Chemistry & Molecular Pharmacology
Mark S. Cushman, Medicinal Chemistry & Molecular Pharmacology
Mingji Dai, Organic Chemistry
V. Jo Davisson, Medicinal Chemistry & Molecular Pharmacology
Emily Dykhuizen, Medicinal Chemistry & Molecular Pharmacology
Jennifer Freeman, Health Sciences
Philip L. Fuchs, Organic Chemistry
Arun K. Ghosh, Chemistry and Medicinal Chemistry & Molecular Pharmacology
Tony R. Hazbun, Medicinal Chemistry & Molecular Pharmacology
Qing Jiang, Nutrition Science
Deborah W. Knapp, Co-leader, Veterinary Clinical Sciences
Casey Krusemark, Medicinal Chemistry & Molecular Pharmacology
Markus Lill, Medicinal Chemistry & Molecular Pharmacology
Mark A. Lipton, Chemistry
Philip S. Low, Chemistry
Sulma I. Mohammed, Comparative Pathobiology
Laurie Parker, Medicinal Chemistry & Molecular Pharmacology
Jeannie Poulson, Veterinary Clinical Sciences
John J. Turek, Basic Medical Sciences
David J. Waters, Veterinary Clinical Sciences
Click here to view our entire membership list.